NLF-MO

N/A

Report date: 2025/09/05 17:15:19
NME

Base Information

Drug NameNLF-MO
Drug Alias NameNLF-MO
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionSynuclein alpha modulators
TargetsSynuclein alpha
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesnLife Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesnLife Therapeutics SL
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A